PPI-associated Risks Exaggerated Based on ‘Poor Scientific Data’

The portrayal of proton pump inhibitors in the news lately has been rather bleak. Concerns for increased risks for dementia, malignancies and other serious adverse events have populated our television sets and mainstream media over the last several years.While there are increased risks for certain negative side effects associated with PPIs, those risks are fairly rare.This month’s cover story (page 26) focuses on the fears associated with the use of PPIs and how there is very little available evidence that validates these growing concerns.Both Colin W. Howden, MD, FACG, and John E.Read More

Share on facebook
Share on twitter
Share on linkedin